Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease
University of Alberta
$55,000.00
Does Point-of-Care Abdominal Ultrasound Improve Outcomes in Inflammatory Bowel Disease Patients?
EF 2013-14
Résumé
Monitoring Inflammatory Bowel Disease with Point-of-Care Ultrasound
Inflammatory bowel disease (IBD) is characterized by periods of inactive and active disease. According to the Canadian Digestive Health Foundation, more than 250 000 Canadians are living with IBD. By detecting and treating this disease early on, we can improve a patient's quality of life and decrease the need for surgeries and hospitalizations. Current methods used to monitor the activity of IBD include a clinical assessment by a physician, blood tests, colonoscopies, and CT scans (computed tomography). These tests may have limited accuracy (clinical assessment and blood tests), are invasive (colonoscopy), expose the patient to radiation (CT scan) and are expensive.
As a result, our study is interested in using point-of-care (ie. at the bedside in a doctors office) abdominal ultrasound (US), a type of scan without radiation, to monitor if a patient's IBD is active. We are studying this because abdominal US has been shown to be effective in identifying active IBD. Our first study objective is to determine if incorporating US every 12 weeks into the monitoring of a patient's IBD, and using the US result to guide us in making early treatment changes, will increase the length of time a patient remains healthy. Our second study objective is to determine the accuracy of US in revealing active IBD and to relate these findings with our current methods of detecting active IBD. This objective will improve the monitoring and subsequent treatment of IBD suffered by Canadians with a non-invasive and accurate US method. In summary, this research project will advance the care of Canadians with IBD by showing that point-of-care (bedside) abdominal US can be readily used to detect IBD activity and to help us adjust treatment.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
302341
Name
Lu Cathy
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Does Point-of-Care Abdominal Ultrasound Improve Outcomes in Inflammatory Bowel Disease Patients?
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$55,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
C-Reactive Protein; Cohort Study; Crohn'S Disease; Crohn'S Disease Acitivity Index; Endoscopy; Fecal Calprotectin; Genetic Microarray; Harvey Bradshaw Index; Point Of Care Abdominal Ultrasound; Prospective Study
Abstract
Monitoring Inflammatory Bowel Disease with Point-of-Care Ultrasound
Inflammatory bowel disease (IBD) is characterized by periods of inactive and active disease. According to the Canadian Digestive Health Foundation, more than 250 000 Canadians are living with IBD. By detecting and treating this disease early on, we can improve a patient's quality of life and decrease the need for surgeries and hospitalizations. Current methods used to monitor the activity of IBD include a clinical assessment by a physician, blood tests, colonoscopies, and CT scans (computed tomography). These tests may have limited accuracy (clinical assessment and blood tests), are invasive (colonoscopy), expose the patient to radiation (CT scan) and are expensive.
As a result, our study is interested in using point-of-care (ie. at the bedside in a doctors office) abdominal ultrasound (US), a type of scan without radiation, to monitor if a patient's IBD is active. We are studying this because abdominal US has been shown to be effective in identifying active IBD. Our first study objective is to determine if incorporating US every 12 weeks into the monitoring of a patient's IBD, and using the US result to guide us in making early treatment changes, will increase the length of time a patient remains healthy. Our second study objective is to determine the accuracy of US in revealing active IBD and to relate these findings with our current methods of detecting active IBD. This objective will improve the monitoring and subsequent treatment of IBD suffered by Canadians with a non-invasive and accurate US method. In summary, this research project will advance the care of Canadians with IBD by showing that point-of-care (bedside) abdominal US can be readily used to detect IBD activity and to help us adjust treatment.
Competitiondate
201311
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Lu, Cathy
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $55,000~ $0~